Prime Capital Investment Advisors LLC Increases Stake in Cardinal Health, Inc. $CAH

Prime Capital Investment Advisors LLC boosted its stake in Cardinal Health, Inc. (NYSE:CAH) by 18.4% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 7,392 shares of the company’s stock after purchasing an additional 1,150 shares during the period. Prime Capital Investment Advisors LLC’s holdings in Cardinal Health were worth $1,242,000 at the end of the most recent reporting period.

A number of other large investors have also bought and sold shares of the stock. JPMorgan Chase & Co. increased its stake in Cardinal Health by 40.0% in the 1st quarter. JPMorgan Chase & Co. now owns 4,175,992 shares of the company’s stock worth $575,327,000 after purchasing an additional 1,193,983 shares during the period. Northern Trust Corp increased its stake in shares of Cardinal Health by 3.5% during the first quarter. Northern Trust Corp now owns 3,143,003 shares of the company’s stock valued at $433,012,000 after buying an additional 105,154 shares during the period. Wellington Management Group LLP raised its holdings in shares of Cardinal Health by 1,666.7% during the first quarter. Wellington Management Group LLP now owns 2,384,192 shares of the company’s stock valued at $328,470,000 after acquiring an additional 2,249,241 shares in the last quarter. Price T Rowe Associates Inc. MD raised its holdings in shares of Cardinal Health by 3.3% during the first quarter. Price T Rowe Associates Inc. MD now owns 1,654,036 shares of the company’s stock valued at $227,877,000 after acquiring an additional 52,714 shares in the last quarter. Finally, Dimensional Fund Advisors LP raised its holdings in shares of Cardinal Health by 0.6% during the first quarter. Dimensional Fund Advisors LP now owns 1,246,788 shares of the company’s stock valued at $171,749,000 after acquiring an additional 7,940 shares in the last quarter. 87.17% of the stock is owned by hedge funds and other institutional investors.

Cardinal Health Stock Up 0.7%

Shares of CAH stock opened at $157.77 on Thursday. The stock has a market cap of $37.48 billion, a price-to-earnings ratio of 24.46, a PEG ratio of 1.32 and a beta of 0.71. The business’s fifty day moving average is $152.03 and its 200 day moving average is $150.75. Cardinal Health, Inc. has a twelve month low of $106.98 and a twelve month high of $168.44.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share for the quarter, topping the consensus estimate of $2.03 by $0.05. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The company had revenue of $60.16 billion for the quarter, compared to analysts’ expectations of $60.91 billion. During the same period in the prior year, the firm earned $1.84 earnings per share. The firm’s revenue for the quarter was up .5% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. Equities research analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st will be issued a $0.5107 dividend. This represents a $2.04 annualized dividend and a yield of 1.3%. The ex-dividend date of this dividend is Wednesday, October 1st. Cardinal Health’s payout ratio is 31.63%.

Insiders Place Their Bets

In other Cardinal Health news, insider Jessica L. Mayer sold 38,078 shares of the business’s stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total value of $5,666,767.96. Following the sale, the insider directly owned 48,457 shares of the company’s stock, valued at approximately $7,211,370.74. The trade was a 44.00% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Ola M. Snow sold 28,151 shares of the business’s stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $148.94, for a total value of $4,192,809.94. Following the completion of the sale, the insider directly owned 15,431 shares in the company, valued at $2,298,293.14. This trade represents a 64.59% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 271,676 shares of company stock valued at $40,489,525. Company insiders own 0.12% of the company’s stock.

Analyst Ratings Changes

A number of brokerages recently commented on CAH. Wells Fargo & Company restated an “overweight” rating and set a $185.00 target price (up previously from $183.00) on shares of Cardinal Health in a report on Wednesday, August 13th. Jefferies Financial Group set a $150.00 target price on Cardinal Health in a report on Tuesday, August 12th. Citigroup restated a “neutral” rating and set a $170.00 target price (up previously from $157.00) on shares of Cardinal Health in a report on Friday, June 13th. Robert W. Baird upped their target price on Cardinal Health from $197.00 to $203.00 and gave the company an “outperform” rating in a report on Wednesday, August 13th. Finally, Morgan Stanley restated an “overweight” rating on shares of Cardinal Health in a report on Tuesday, August 12th. Twelve investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $166.00.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.